Cryo-Cell Stock (NASDAQ:CCEL)
Previous Close
$7.34
52W Range
$3.67 - $9.50
50D Avg
$6.40
200D Avg
$6.94
Market Cap
$58.13M
Avg Vol (3M)
$10.71K
Beta
0.53
Div Yield
$1.00
CCEL Company Profile
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
CCEL Performance
Peer Comparison
| Ticker | Company |
|---|---|
| AIH | Aesthetic Medical International Holdings Group Limited |
| SGRY | Surgery Partners, Inc. |
| TOI | The Oncology Institute, Inc. |
| BKD | Brookdale Senior Living Inc. |
| CCM | Concord Medical Services Holdings Limited |
| INNV | InnovAge Holding Corp. |
| PNTG | The Pennant Group, Inc. |
| AVAH | Aveanna Healthcare Holdings Inc. |
| SNDA | Sonida Senior Living, Inc. |
| DCGO | DocGo Inc. |
| EHC | Encompass Health Corporation |
| ACHC | Acadia Healthcare Company, Inc. |
| MD | Pediatrix Medical Group, Inc. |
| SEM | Select Medical Holdings Corporation |
| AIRS | AirSculpt Technologies, Inc. |
| ENSG | The Ensign Group, Inc. |
| PIII | P3 Health Partners Inc. |